Invasive pneumococcal disease
Conditions
Interventions
Intervention type:
Name of intervention:
Dose form / Japanese Medical Device Nomenclature:
Route of administration / Site of application:
Dose per administration:
Dosing frequency / Frequency of use:
Sponsors
Takaya Maruyama, Department of respiratory medicine, National hospital Organization Mie National Hospital
National hospital Organization Tokyo National Hospital, National hospital Organization Hokkaido Medical Center, Keio University, Kyoto University, Nagasaki University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with IPD 1) S. pneumoniae is isolated from physiologically sterile site [spinal fluid, blood, etc]. 2)Diagnosed as bacterial meningitis, bacteremia, bacteremic pneumonia, arthritis, peritonitis
Exclusion criteria
Exclusion criteria: Patients with IPD 1) S. pneumoniae is not isolated from sterile site . 2)Not diagnosed as bacterial meningitis, bacteremia, bacteremic pneumonia, arthritis, peritonitis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To analyze the serotype distribution, drug sensitivity and genotypes of S.pneumoniae isolated from adult patients with IPD 2)To evaluate outcome, risk factors of drug resistance and prognostic factors in the patients with IPD | — |
Countries
Japan
Contacts
Public ContactTakaya Maruyama
National hospital Organization Mie National Hospital
Outcome results
None listed